UNMC to start third phase of federal COVID-19 drug trial
Omaha World-Herald’s Julie Anderson reports that a new phase of testing COVID-19 drugs is expected to begin this week at University of Nebraska Medical Center. Read more
BIO Announces BIOEquality Agenda
The BIOEquality Agenda is a national effort in collaboration with BIO’s partners and member organizations in the biotechnology sector that aims to counteract the systemic inequality, injustice, and unfair treatment of underserved communities. Read more
IowaBio and Bio Nebraska Announce Secretary Naig and Director Wellman to Present at Animal Health in the Heartland Symposium
IowaBio and Bio Nebraska announced today that Mike Naig, Iowa Secretary of Agriculture, and Steve Wellman, Director of the Nebraska Department of Agriculture, will present at the Animal Health in the Heartland virtual symposium. Read more
Member Spotlight: DNA Genetics
Tom Rathje, Ph.D., MBA, DNA Genetics’ Chief Technical Officer, talks to us about America’s pork industry, the outlook for the company, serving customers during COVID-19, and more. Read more
Paper highlights COVID-19 disparities
A recent study published by a team at UNMC finds that systemic social inequality contributes to COVID-19 disparities. Read more
UNMC secures $174.2 million in outside funding, some for COVID-19 research and clinical trials
Omaha World-Herald’s Julie Anderson reports that University of Nebraska Medical Center and University of Nebraska at Omaha have both secured funding from outside sources in 2020. Read more
Allies for Nebraska agriculture
Midwest Messenger’s Jon Burleson explores Bio Nebraska member Nebraska Public Power District’s work to recruit and retain businesses in the state. Read more
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study
Pfizer, a Bio Nebraska member, and BioNTech SE announced this week the start of a global 2/3 safety and efficacy clinical study for a COVID-19 vaccine, with two Nebraska locations included in the research. Read more
BIO’s Dr. McMurry-Heath Warns Executive Order to “Cripple Small, Innovative Companies” Working to Eradicate COVID-19
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a statement last week warning that an executive order to adopt foreign price controls on certain prescription medicines could “cripple” companies working to eradicate COVID-19 and lead to less patient access to lifesaving treatments. Read more
Japan Trade Mission and Roadshow for U.S. Medical Device Companies
The US–Japan Healthcare Connection, a collaboration between U.S. Japan Medtech Frontiers (USJMF) and The Japan Society of Northern California (JSNC), is proud to announce the 2020 Virtual Japan Trade Mission and Roadshow for Medical Device Companies September 14-17, 2020. Read more